Welch Daniel G

Welch Daniel G is listed in filings as Director at Prothena Corporation plc. This profile follows SEC Form 4 activity through May 18, 2026, including 10 public disclosures. Recent filings connect the profile to Prothena Corporation plc (PRTA), Ultragenyx Pharmaceutical Inc (RARE), and Structure Therapeutics Inc (GPCR). The current snapshot covers public activity from Jun 20, 2024 to May 18, 2026. Reported amounts are shown as $263.5K to $381.8K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.